Lymphodepleting pre-conditioning using irradiation and/or chemotherapy can improve CAR T cell abundance by killing tumor cells, reducing competition for IL7 and IL15, and decreasing regulatory T cells (8–11). This evidence concerns the gene IL7 and neoplasm.